Limes Schlosskliniken AG
ISIN: DE000A0JDBC7
WKN: A0JDBC
18 July 2024 10:17AM

EQS-Adhoc: Limes Schlosskliniken AG: Positive business performance in the first half of 2024

Limes Schlosskliniken AG · ISIN: DE000A0JDBC7 · EQS - adhoc news
Country: Germany · Primary market: Germany · EQS NID: 1949233

EQS-Ad-hoc: Limes Schlosskliniken AG / Key word(s): Half Year Report/Preliminary Results
Limes Schlosskliniken AG: Positive business performance in the first half of 2024

18-Jul-2024 / 10:17 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


DGAP-Adhoc: Limes Schlosskliniken AG:

Positive business performance in the first half of 2024

  • Total revenue EUR 18.8m  + 33 %
     
  • Patient days 24,731  + 40 %
     
  • Gross earnings (EBITDA)  3,689 kEUR  + 28 %
     
  • Operating result (EBIT)  2,244 kEUR  + 25 %
     
  • Earnings before taxes 2,003 kEUR  + 24 %
     

Cologne, July 18, 2024: In the first half of 2024, the LIMES Group increased its total revenue by + 33 % to EUR 18.8 million. Overall, 40 % more patients were treated in the first six months, resulting in an increase in billed patient days to 24,731. The occupancy rate at the german LIMES Schlosskliniken developed positive. The performance of the PRC Zurich was temporarily weaker. However, we expect a significantly stronger second half-year there. The half-year figures include start-up costs for the two new locations amounting to 360 kEUR. Business development in the first half of the year was driven by the good operating performance of the existing LIMES clinics and the consolidation of Clinicum Alpinum.

The opening of the new LIMES Schlossklinik Abtsee is planned for the beginning of 2025. The handover of the second new clinic, LIMES Schlossklinik Bergisches Land, is scheduled for April 1, 2025. This will provide the LIMES Group with an additional 180 treatment places in 2025.

We are pleased that the LIMES brand stands for high-quality psychiatric services in the spectrum of stress-related illnesses, depression, trauma and personality disorders and is increasingly being well received on the market.

The detailed half-year report of LIMES Schlosskliniken will be published on September 3, 2024.

Brief profile: The LIMES Schlosskliniken Group operates high-quality private clinics for stress-related illnesses, mental and emotional disorders, such as depression, affective disorders and acute burnout conditions. The range of services is aimed at private patients, those entitled to subsidies and self-payers. The LIMES Schlosskliniken Group stands for the special approach of a relationship-oriented medicine in the treatment of people with mental illnesses. In addition to top medical quality, patients are offered a unique, protected and healing environment in which they can recover holistically. Further information is available at www.limes-schlosskliniken.de.

Your contact person:
LIMES Schlosskliniken AG, Petra Kaes, Investor Relations
Kaiser-Wilhelm-Ring 26, 50672 Cologne
Tel.: 0221 669 615 10, p.kaes@limes.care, www.limes-schlosskliniken.de

Language:  German
Company: LIMES Schlosskliniken AG, Kaiser-Wilhelm-Ring 26, 50672 Cologne, Germany
Phone:   49 221 669 615 10
Mail:  p.kaes@limes.care
Internet:  www.limes-schlosskliniken.de
ISIN:  DE000A0JDBC7
WKN:  AOJDBC
Stock exchange: Düsseldorf Open Market, Primary Market, XETRA

End of the message



End of Inside Information

18-Jul-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Limes Schlosskliniken AG
Kaiser-Wilhelm-Ring 26
50672 Köln
Germany
ISIN: DE000A0JDBC7
WKN: A0JDBC
Listed: Regulated Unofficial Market in Dusseldorf
EQS News ID: 1949233

 
End of Announcement EQS News Service

1949233  18-Jul-2024 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1949233&application_name=news&site_id=boersengefluester~~~ace3d64b-2049-452a-8d18-fbc8044c4b5f

Boersengefluester.de (BGFL) provides an overview of the key figures on sales, earnings, cash flow and dividends to help you better assess the fundamental development of the respective companies. All information is entered manually in our database - the source is the respective annual reports. All estimates for future figures are provided by BGFL.

The most important financial data at a glance
  2018 2019 2020 2021 2022 2023 2024e
Sales1 7,43 8,18 11,02 23,44 28,81 37,17 44,00
EBITDA1,2 -0,13 0,26 0,84 6,02 8,65 7,67 9,80
EBITDA-Margin3 -1,75 3,18 7,62 25,68 30,02 20,64 22,27
EBIT1,4 -0,93 -0,54 -0,43 4,53 6,00 5,03 7,00
EBIT-Margin5 -12,52 -6,60 -3,90 19,33 20,83 13,53 15,91
Net Profit (Loss)1 -1,46 -0,83 -0,69 4,11 4,86 3,91 4,60
Net-Margin6 -19,65 -10,15 -6,26 17,53 16,87 10,52 10,46
Cashflow1,7 -0,66 0,17 0,76 4,77 8,04 6,29 0,00
Earnings per share8 -5,78 -2,81 -2,37 13,45 14,34 11,58 14,10
Dividend per share8 0,00 0,00 0,00 0,00 0,00 0,00 0,00
Quelle: boersengefluester.de and Company information
Explanation

1 in Mio. Euro; 2 EBITDA = Earnings before interest, taxes, depreciation and amortisation; 3 EBITDA in relation to sales; 4 EBIT = Earnings before interest and taxes; 5 EBIT in relation to sales; 6 Net profit (-loss) in relation to sales; 7 Cashflow from operations; 8 in Euro; Source: boersengefluester.de

Auditor: B-S-H Collegen

All relevant valuation ratios, dates and other investor information on your share at a glance. Good to know: All data comes from boersengefluester.de and is updated daily. This means you are always up to date. You can get brief explanations of the key figures by moving the cursor or mouse over the relevant field.

INVESTOR-INFORMATION
©boersengefluester.de
Limes Schlosskliniken
WKN ISIN Legal Type Marketcap IPO Recommendation Plus Code
A0JDBC DE000A0JDBC7 AG 94,99 Mio € 12.10.2018 Kaufen 9F28WWVR+CQ
* * *
PE 2025e PE 10Y-Ø BGFL-Ratio Shiller-PE PB PCF KUV
19,17 21,28 0,90 69,01 6,28 15,10 2,56
Dividends
Dividend '2022
in €
Dividend '2023
in €
Dividend '2024e
in €
Div.-Yield '2024e
in %
0,00 0,00 0,00 0,00%
Financial calendar
Annual General Meeting Q1-figures Q2-figures Q3-figures Annual press conference
06.06.2025 03.09.2024 16.05.2025
Performance
Distance 60-days-line Distance 200-days-line Performance YtD Performance 52 weeks IPO
Last Price (EoD)
+1,89%
324,00 €
ATH 390,00 €
-6,32% -7,77% +14,08% +14,08% +208,57%

Advertising is an important revenue channel for us. But we understand, that sometimes it becomes annoying. If you want to reduce the number of shown ADs just simply login to your useraccount and manage the settings from there. As registered user you get even more benefits.
          Qualitätsjournalismus · Made in Germany © 2024          
The news manufactory

Good luck with all your investments

Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.

Contact

Idea & concept: 3R Technologies   
boersengefluester.de GmbH Copyright © 2024 by Gereon Kruse #BGFL